Syrentis Clinical Research

Syrentis Clinical Research is a multi-specialty clinical research institute which conducts FDA approved clinical trials with an emphasis in CNS disorders (Alzheimers dementia, Mild Cognitive Impairment (MCI), major depressive disorder, treatment resistant depression, anxiety disorders, insomnia), as well as diabetes mellitus, COPD, peripheral neuropathy, cardiovascular disease, fibromyalgia, hypercholesterolemia, hypertension, chronic pain, endocrine disorders, weight loss, binge eating, metabolic syndrome, claudication, PVD, birth control and dermatologic disorders. Additionally, we assist with the development of new drug delivery systems, including vaccines, inhalers, IM/IV injections, auto-injectors and topical/patch systems. We have conducted studies using medical devices and we conduct Human Factor product evaluations...

Dementia,memory loss,copd,a-fib,depression,tourette's,hypertriglyceridimia,mild cognitive impairment,memory loss,fibromyalgia,chronic pain,weight loss,binge eating,acne,clinical trials,alzheimer's,medical device studies,and delivery systems

Syrentis clinical research operates in the Research services industry.

Syrentis clinical research's revenue is 11m - 100m

Syrentis clinical research has 11 - 50 employees.